News
Plug Power: Business Is Looking To Be Unviable (NASDAQ:PLUG)
Back in April, I wrote that I'd stay away from Plug Power (NASDAQ:PLUG) until it can better prove itself, while…
Global Blue: This Forgotten Market Leader Could Be Set To Double (NYSE:GB)
Global Blue (NYSE:GB) is a company indirectly exposed to international travel and luxury goods. It is a clear market leader…
Week In Review: Two Billion-Dollar Deals As 2023 Nears End – Hansoh-GSK; Nona-Pfizer
Deals and Financings GSK acquired ex-Greater China rights to a second ADC from Jiangsu’s Hansoh Pharma in a $1.7 billion…
Brookfield Infrastructure: Learn To Avoid Unreasonable Pessimism Next Time (NYSE:BIP)
Brookfield Infrastructure (NYSE:BIP) (NYSE:BIPC) is a high-quality global infrastructure-focused player. Its assets portfolio generates "contracted and regulated revenues," providing holders…
ESCO Technologies: Why I Believe It Will Continue Its Growth (NYSE:ESE)
Thesis ESCO Technologies (NYSE:NYSE:ESE) presents an interesting investment opportunity, underpinned by strategic growth initiatives such as the acquisition of CMT…
Preferreds Weekly Review: AAIC Delists Its Bonds
Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity…
ACWI: A Stellar End To 2023, Eyeing Early-2024 Election-Year Risks (NASDAQ:ACWI)
It has been quite a year for global stocks. Large-cap US equities led the way through July before a garden-variety…
A Deeper Look At Ultragenyx Pharmaceuticals (NASDAQ:RARE)
Repetition of an argument proves your determination, not truth.”― Raheel Farooq Shares of rare disease concern Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)…